LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 611

Search options

  1. Article ; Online: Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study.

    Saito, Yuta / Kizaki, Junichiro / Wada, Yoshihiro / Shibasaki, Yoshiyuki / Kishimoto, Nobuharu / Aihara, Makoto

    Japanese journal of ophthalmology

    2021  Volume 65, Issue 5, Page(s) 598–607

    Abstract: Purpose: To evaluate the 24-h efficacy and safety of fixed combination carteolol/latanoprost (LCFC ... over after a 2-month treatment period. The 24-h curves of intraocular pressure (IOP), pulse rate, and ... between the groups.: Conclusion: The 24-h IOP curve of patients in the LCFC group was similar ...

    Abstract Purpose: To evaluate the 24-h efficacy and safety of fixed combination carteolol/latanoprost (LCFC) and timolol/latanoprost (LTFC) in patients with primary open-angle glaucoma and ocular hypertension.
    Study design: Prospective, randomized, crossover study METHODS: Twenty-two patients pretreated with a prostaglandin analog at baseline were randomly assigned at a 1:1 ratio to either LCFC or LTFC treatment. The patients received the assigned study drug in both eyes daily in the evening (20:00). Each treatment group crossed over after a 2-month treatment period. The 24-h curves of intraocular pressure (IOP), pulse rate, and blood pressure were evaluated. Safety was also assessed.
    Results: The changes in mean daytime IOP from baseline at the end of the 2-month treatment period in the LCFC and LTFC groups were  - 0.93 and  - 1.15 mmHg, respectively. The changes in peak IOP in the 2 groups were  - 0.91 and  - 0.68 mmHg, respectively. The nighttime pulse rate in the LCFC group increased; that in the LTFC group was lower at all time points. The changes in pulse rate from baseline at 22:00, 2:00, 4:00, and 6:00 differed statistically between the 2 groups. No differences in changes from baseline in systolic and diastolic blood pressures were found between the groups.
    Conclusion: The 24-h IOP curve of patients in the LCFC group was similar to that of the LTFC group, but on the basis of the pulse rate findings, the effect of LCFC on the cardiovascular system over 24 h was less than that of LTFC.
    MeSH term(s) Antihypertensive Agents/adverse effects ; Carteolol ; Cross-Over Studies ; Drug Combinations ; Glaucoma, Open-Angle/diagnosis ; Glaucoma, Open-Angle/drug therapy ; Humans ; Intraocular Pressure ; Latanoprost ; Ocular Hypertension/diagnosis ; Ocular Hypertension/drug therapy ; Prospective Studies ; Prostaglandins F, Synthetic ; Timolol ; Treatment Outcome
    Chemical Substances Antihypertensive Agents ; Drug Combinations ; Prostaglandins F, Synthetic ; Latanoprost (6Z5B6HVF6O) ; Timolol (817W3C6175) ; Carteolol (8NF31401XG)
    Language English
    Publishing date 2021-07-19
    Publishing country Japan
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 82032-5
    ISSN 1613-2246 ; 0021-5155
    ISSN (online) 1613-2246
    ISSN 0021-5155
    DOI 10.1007/s10384-021-00856-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A cross-sectional survey of hepatitis B virus screening in patients who received immunosuppressive therapy for rheumatoid arthritis in Japan.

    Yanagisawa, Yuki / Imai, Shungo / Kizaki, Hayato / Hori, Satoko

    Journal of pharmaceutical health care and sciences

    2024  Volume 10, Issue 1, Page(s) 18

    Abstract: Background: Patients with a history of hepatitis B virus (HBV) infection who are receiving immunosuppressive therapy are at risk of HBV reactivation and disease. Therefore, HBV screening is required prior to administering antirheumatic drugs with ... ...

    Abstract Background: Patients with a history of hepatitis B virus (HBV) infection who are receiving immunosuppressive therapy are at risk of HBV reactivation and disease. Therefore, HBV screening is required prior to administering antirheumatic drugs with immunosuppressive effects. This study aimed to determine the status of hepatitis B surface antigen (HBsAg), hepatitis B core antibody (HBcAb), and hepatitis B surface antibody (HBsAb) screening prior to the initiation of drug therapy, including new antirheumatic drugs, in patients with rheumatoid arthritis.
    Methods: This retrospective cross-sectional study used data from April 2014 to August 2022 from the Japanese hospital-based administrative claims database. The inclusion criteria were rheumatoid arthritis and first prescription date of antirheumatic drugs.
    Results: A total of 82,282 patients with rheumatoid arthritis who were first prescribed antirheumatic drugs between April 2016 and August 2022 were included. Of the eligible patients, 9.7% (n=7,959) were screened for all HBV (HBsAg, HBsAb, and HbcAb) within 12 months prior to the date of initial prescription. The HBsAg test was performed in 30.0% (n=24,700), HBsAb test in 11.8% (n=9,717), and HBcAb test in 13.1% (n=10,824) of patients. The proportion of patients screened for HBV infection has been increasing since 2018; however, the proportion of patients screened for rheumatoid arthritis remains low.
    Conclusions: Our findings suggest that HBV screening may be insufficient in patients who received antirheumatic drugs. With the increasing use of new immunosuppressive antirheumatic drugs, including biological agents, healthcare providers should understand the risk of HBV reactivation and conduct appropriate screening.
    Language English
    Publishing date 2024-04-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2809913-8
    ISSN 2055-0294
    ISSN 2055-0294
    DOI 10.1186/s40780-024-00339-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Comparison of different sustained-release opioids and acute respiratory conditions in patients with cancer and chronic kidney disease.

    Mitsuboshi, Satoru / Imai, Shungo / Kizaki, Hayato / Hori, Satoko

    Pharmacotherapy

    2023  Volume 44, Issue 2, Page(s) 122–130

    Abstract: Study objective: Few data are available on the association between the use of oxycodone in patients with chronic kidney disease (CKD) and acute respiratory conditions. The aim of this study was to investigate whether oxycodone is associated with an ... ...

    Abstract Study objective: Few data are available on the association between the use of oxycodone in patients with chronic kidney disease (CKD) and acute respiratory conditions. The aim of this study was to investigate whether oxycodone is associated with an increased risk of acute respiratory conditions in patients with cancer and CKD compared with other opioids.
    Design and setting: The data were obtained from a claims database in Japan. Patients with cancer and CKD who had received sustained-release opioids, including oral oxycodone, oral morphine, or transdermal fentanyl, between April 2014 and May 2021 were selected. The primary outcome was defined as an acute respiratory condition. Data for age and sex, morphine equivalent daily dose, concomitant use of specified medications, comorbidities defined based on the modified Charlson comorbidity index, substance use disorder, and lung cancer or metastatic lung cancer were investigated as covariates. Distribution of acute respiratory conditions was compared among the three sustained-release opioid groups using the log-rank test. Estimates of the incidence of acute respiratory conditions were compared among the groups using a Cox proportional hazards model with time-varying variables.
    Main results: A significant difference in the distribution of acute respiratory conditions was found among the three groups (p < 0.01). Cox regression analysis showed a significantly higher risk of acute respiratory conditions with morphine (hazard ratio [HR]: 3.04, 95% confidence interval [CI]: 1.07-8.65, p = 0.04) compared with oxycodone but no significant difference in risk with oxycodone (HR 0.67, 95% CI: 0.32-1.38, p = 0.27) compared with fentanyl.
    Conclusions: The findings suggest that the risk of acute respiratory conditions may be lower in patients with CKD who use oxycodone for cancer pain than in those who use morphine. Additionally, no difference in the risk of acute respiratory conditions was found between oxycodone and fentanyl use.
    MeSH term(s) Humans ; Analgesics, Opioid/adverse effects ; Oxycodone/adverse effects ; Pain/drug therapy ; Delayed-Action Preparations/therapeutic use ; Fentanyl/adverse effects ; Morphine/adverse effects ; Renal Insufficiency, Chronic/complications ; Neoplasms/chemically induced ; Lung Neoplasms/epidemiology
    Chemical Substances Analgesics, Opioid ; Oxycodone (CD35PMG570) ; Delayed-Action Preparations ; Fentanyl (UF599785JZ) ; Morphine (76I7G6D29C)
    Language English
    Publishing date 2023-11-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603158-4
    ISSN 1875-9114 ; 0277-0008
    ISSN (online) 1875-9114
    ISSN 0277-0008
    DOI 10.1002/phar.2892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Influence of Voiced and Semi-voiced Sounds on the Subjective Similarity of Different Drug Names: A Cognitive Psychological Experiment.

    Yoshikawa, Kodai / Kizaki, Hayato / Imai, Shungo / Hori, Satoko

    Biological & pharmaceutical bulletin

    2023  Volume 46, Issue 11, Page(s) 1630–1634

    Abstract: The similarity of drug names is one of the common causes of medication error. In Japan, similarity evaluation is performed prior to approval of new drugs in order to avoid potential confusion. However, existing indices do not take account of the ... ...

    Abstract The similarity of drug names is one of the common causes of medication error. In Japan, similarity evaluation is performed prior to approval of new drugs in order to avoid potential confusion. However, existing indices do not take account of the difference between characters that contain voiced or semi-voiced and unvoiced sounds, so it is not clear whether such sounds influence the subjective similarity of drug names. Thus, we performed a cognitive psychological experiment to investigate this issue, using participants who had not received any education in medicine, nursing, or pharmacy. An analogue scale questionnaire was used to evaluate the subjective similarity of the names of drug pairs. Drug pairs for the main analysis were prepared by matching the first 0 to 3 characters, and then varying the difference in the number of voiced and semi-voiced characters from 0 to 3 in these matched characters. By means of this procedure, the drug pairs were classified into a total of 10 groups. Then, a total of 60 drug pairs were created by assigning 6 drugs to each group. The subjective similarity tended to increase with increasing number of common characters among the first three characters. When classified according to the number of these common characters, the subjective similarity was significantly decreased when voiced or semi-voiced sounds were present, as compared with when they were absent. These results indicate that a new drug name similarity index that takes account of voiced and semi-voiced sound differences should be developed to minimize medication errors.
    MeSH term(s) Humans ; Medication Errors ; Sound ; Pharmacies ; Cognition ; Japan
    Language English
    Publishing date 2023-11-01
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1150271-x
    ISSN 1347-5215 ; 0918-6158
    ISSN (online) 1347-5215
    ISSN 0918-6158
    DOI 10.1248/bpb.b23-00396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Preincubation of thymocytes with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) induces apoptosis in non-stimulated thymocytes.

    Sakurai, Y / Hirata, C / Onishi, Y / Tanimoto, Y / Yamada, T / Kizaki, H

    Biochemistry and molecular biology international

    1997  Volume 42, Issue 3, Page(s) 433–441

    Abstract: 1-(5-Isoquinolinesulfonyl1)-2-methylpiperazine hydrochloride (H-7), an inhibitor of protein kinases ... In the present study, when mouse thymocytes were pretreated with H-7, washed, and cultured for an additional time ... apoptosis was induced depending on the preincubation time and the dose of H-7. The protein kinase C activity ...

    Abstract 1-(5-Isoquinolinesulfonyl1)-2-methylpiperazine hydrochloride (H-7), an inhibitor of protein kinases, has been shown to inhibit the thymocyte apoptosis induced by various apoptogenic agents. In the present study, when mouse thymocytes were pretreated with H-7, washed, and cultured for an additional time, apoptosis was induced depending on the preincubation time and the dose of H-7. The protein kinase C activity in the H-7-pretreated and -washed cells was not altered, suggesting that an alteration of a certain PKC isoform is related to both the triggering and the progression of apoptosis.
    MeSH term(s) 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives ; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology ; Animals ; Apoptosis/drug effects ; Benzoquinones ; Calcium-Calmodulin-Dependent Protein Kinase Type 2 ; Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors ; Cells, Cultured ; Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors ; Cycloheximide/pharmacology ; Dactinomycin/pharmacology ; Enzyme Inhibitors/pharmacology ; Isoenzymes/antagonists & inhibitors ; Isoenzymes/physiology ; Isoquinolines/pharmacology ; Lactams, Macrocyclic ; Male ; Mice ; Mice, Inbred BALB C ; Nucleic Acid Synthesis Inhibitors/pharmacology ; Phosphorylation/drug effects ; Protein Kinase C/antagonists & inhibitors ; Protein Kinase C/physiology ; Protein Processing, Post-Translational/drug effects ; Protein Synthesis Inhibitors/pharmacology ; Quinones/pharmacology ; RNA/biosynthesis ; Rifabutin/analogs & derivatives ; Sulfonamides ; T-Lymphocytes/drug effects ; Thymus Gland/cytology
    Chemical Substances Benzoquinones ; Enzyme Inhibitors ; Isoenzymes ; Isoquinolines ; Lactams, Macrocyclic ; Nucleic Acid Synthesis Inhibitors ; Protein Synthesis Inhibitors ; Quinones ; Sulfonamides ; Dactinomycin (1CC1JFE158) ; Rifabutin (1W306TDA6S) ; RNA (63231-63-0) ; KN 62 (63HM46XPOW) ; herbimycin (70563-58-5) ; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine (84477-87-2) ; N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (91742-10-8) ; Cycloheximide (98600C0908) ; Cyclic AMP-Dependent Protein Kinases (EC 2.7.11.11) ; Protein Kinase C (EC 2.7.11.13) ; Calcium-Calmodulin-Dependent Protein Kinase Type 2 (EC 2.7.11.17) ; Calcium-Calmodulin-Dependent Protein Kinases (EC 2.7.11.17) ; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide (M876330O56)
    Language English
    Publishing date 1997-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 1144589-0
    ISSN 1039-9712 ; 0158-5231
    ISSN 1039-9712 ; 0158-5231
    DOI 10.1080/15216549700202841
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Detection of Adverse Event Signals with Severity Grade Classification from Cancer Patient Narrative.

    Nishioka, Satoshi / Asano, Masaki / Yada, Shuntaro / Aramaki, Eiji / Yajima, Hiroshi / Kizaki, Hayato / Hori, Satoko

    Studies in health technology and informatics

    2024  Volume 310, Page(s) 554–558

    Abstract: Adverse event (AE) management is crucial to improve anti-cancer treatment outcomes, but it is reported that some AE signals can be missed in clinical visits. Thus, monitoring AE signals seamlessly, including events outside hospitals, would be helpful for ...

    Abstract Adverse event (AE) management is crucial to improve anti-cancer treatment outcomes, but it is reported that some AE signals can be missed in clinical visits. Thus, monitoring AE signals seamlessly, including events outside hospitals, would be helpful for early intervention. Here we investigated how to detect AE signals from texts written by cancer patients themselves by developing deep-learning (DL) models to classify posts mentioning AEs according to severity grade, in order to focus on those that might need immediate treatment interventions. Using patient blogs written in Japanese by cancer patients as a data source, we built DL models based on three approaches, BERT, ELECTRA, and T5. Among these models, T5 showed the best F1 scores for both Grade ≥ 1 and ≥ 2 article classification tasks (0.85 and 0.53, respectively). This model might benefit patients by enabling earlier AE signal detection, thereby improving quality of life.
    MeSH term(s) Humans ; Quality of Life ; Blogging ; Hospitals ; Narration ; Neoplasms
    Language English
    Publishing date 2024-01-25
    Publishing country Netherlands
    Document type Journal Article
    ISSN 1879-8365
    ISSN (online) 1879-8365
    DOI 10.3233/SHTI231026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Influence of Participation in a Medical-Themed Science Café on Patient Activation.

    Okazawa, Yuta / Kizaki, Hayato / Suzuki, Nobuyuki / Osaka, Wakako / Hori, Satoko

    Patient preference and adherence

    2023  Volume 17, Page(s) 3093–3106

    Abstract: Purpose: This study aims to investigate the impact of a Science Café (SC) dealing with medical topics on participants' patient activation (PA), a concept that refers to patients' involvement in managing their own health, working with their healthcare ... ...

    Abstract Purpose: This study aims to investigate the impact of a Science Café (SC) dealing with medical topics on participants' patient activation (PA), a concept that refers to patients' involvement in managing their own health, working with their healthcare providers, and maintaining their health.
    Material and methods: Semi-structured interviews were conducted with patients who had participated in a medical SC (n = 10) to identify the medical SC-associated factors that influenced PA. Through a questionnaire of medical SC participants (n = 23), the impact on PA and correlations with relevant psychological measures were quantitatively assessed.
    Results: The interviews revealed three factors: "Experience & acceptance of chronic conditions", "Features of medical SC" and "Changes as a result of participation." The questionnaire results showed a positive correlation between PA and resilience and a negative correlation with decision regret.
    Conclusions: Participation in a medical SC by people with illnesses can improve PA by improving knowledge and skills for self-management and increasing self-awareness of illness in a supportive environment. The study highlights the potential benefits of using medical SC as a strategy for healthcare providers to improve PA and health outcomes.
    Language English
    Publishing date 2023-11-28
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2455848-5
    ISSN 1177-889X
    ISSN 1177-889X
    DOI 10.2147/PPA.S424460
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A Survey of the Status of Methadone Switching in Japan Using a Hospital-Based Administrative Claims Database.

    Imai, Shungo / Aoki, Natsumi / Ikegami, Keisuke / Kizaki, Hayato / Hori, Satoko

    Journal of clinical pharmacology

    2023  Volume 64, Issue 2, Page(s) 189–195

    Abstract: Methadone is generally used for the management of cancer pain in patients who cannot obtain adequate analgesia from other strong opioids; however, it has a complicated and inconsistent conversion ratio from pre-switching opioid dosage to methadone. This ... ...

    Abstract Methadone is generally used for the management of cancer pain in patients who cannot obtain adequate analgesia from other strong opioids; however, it has a complicated and inconsistent conversion ratio from pre-switching opioid dosage to methadone. This issue may be pronounced in Japan because only oral tablets are commercially available. We aimed to elucidate the status of methadone switching in Japan, focusing on its dosage. Using a Japanese hospital-based administrative claims database, we included patients who switched to methadone between April 2008 and January 2021. The proportion of methadone switching completion that required more than the defined conversion ratio in the Japanese package insert (called "high-dose methadone switching") was evaluated as a primary endpoint. Other endpoints included "the duration from initiation to completion of methadone switching" and "factors affecting high-dose methadone switching by using multivariate logistic regression analysis". Of 1585 patients who received methadone, 370 were enrolled. Among those, 130 (35.1%) received high-dose methadone switching. The median duration of methadone switching completion (12 days) was longer in the high-dose methadone switching group than in other patients. Four variables were identified as factors affecting high-dose methadone switching. Younger age and outpatient status increased the risk of requiring high-dose methadone switching, whereas the concomitant use of nonsteroidal anti-inflammatory drugs and fentanyl as a pre-switching opioid decreased the risk. In conclusion, more than 30% of the patients underwent high-dose methadone switching and required long completion periods, suggesting that methadone switching remains challenging in Japan.
    MeSH term(s) Humans ; Methadone/therapeutic use ; Analgesics, Opioid ; Japan ; Neoplasms/complications ; Pain
    Chemical Substances Methadone (UC6VBE7V1Z) ; Analgesics, Opioid
    Language English
    Publishing date 2023-10-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.2351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Latent class analysis of patients' background factors affecting the risk of specific adverse drug reactions to dipeptidyl peptidase 4 inhibitors.

    Kaseda, Daigo / Hashiguchi, Masayuki / Kizaki, Hayato / Hori, Satoko

    International journal of clinical pharmacology and therapeutics

    2022  Volume 60, Issue 8, Page(s) 346–357

    Abstract: Background and purpose: Spontaneous reporting is widely used to identify adverse drug reactions (ADRs), but relatively little is known about the relationships between specific ADRs and background factors of affected patients. Here, we applied latent ... ...

    Abstract Background and purpose: Spontaneous reporting is widely used to identify adverse drug reactions (ADRs), but relatively little is known about the relationships between specific ADRs and background factors of affected patients. Here, we applied latent class analysis (LCA) to identify background factors associated with different ADRs in type 2 diabetes patients treated with dipeptidyl peptidase 4 (DPP-4) inhibitors, using the Japanese Adverse Drug Event Report (JADER) database.
    Materials and methods: Patients using only a DPP-4 inhibitor who encountered ADRs were selected from the JADER database up to April 2019 (N = 3,577). LCA was employed to classify these cases based on underlying diseases and lifestyle factors (alcohol, tobacco, diet, and exercise) and to identify characteristic ADRs in each class. The optimum number of classes was determined by selecting the model with the lowest value of the Bayesian information criterion (BIC).
    Results: A six-class model had the lowest BIC, and these classes were characterized by specific background factors and ADRs. For example, one class included diabetes complications, while another class included exercise and diet as background factors. Increased risk of a specific ADR(s), such as pancreatitis or pemphigoid, was found in each class. The nine DPP-4 inhibitors were not uniformly distributed among the classes, though individual classes included patients receiving different inhibitors.
    Conclusion: Our findings indicate that characteristic background factors of patients experiencing specific DPP-4 inhibitor-induced ADRs reported in the JADER database are different and can be classified by LCA. This methodology may be useful for predicting ADRs not detected during drug development.
    MeSH term(s) Adverse Drug Reaction Reporting Systems ; Bayes Theorem ; Diabetes Mellitus, Type 2/drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Drug-Related Side Effects and Adverse Reactions ; Humans ; Hypoglycemic Agents/adverse effects ; Latent Class Analysis
    Chemical Substances Dipeptidyl-Peptidase IV Inhibitors ; Hypoglycemic Agents
    Language English
    Publishing date 2022-06-17
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 124384-6
    ISSN 0946-1965 ; 0340-0026 ; 0300-9718 ; 0174-4879
    ISSN 0946-1965 ; 0340-0026 ; 0300-9718 ; 0174-4879
    DOI 10.5414/CP204192
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Medication incidents associated with the provision of medication assistance by non-medical care staff in residential care facilities.

    Kizaki, Hayato / Yamamoto, Daisuke / Maki, Hideyuki / Masuko, Kotaro / Konishi, Yukari / Satoh, Hiroki / Hori, Satoko / Sawada, Yasufumi

    Drug discoveries & therapeutics

    2024  Volume 18, Issue 1, Page(s) 54–59

    Abstract: The shift towards community-based care in Japan has led to increased medication assistance for older people by non-medical care staff. These staff members help take pre-packaged medications, apply patches, and administer eye drops. This study assessed ... ...

    Abstract The shift towards community-based care in Japan has led to increased medication assistance for older people by non-medical care staff. These staff members help take pre-packaged medications, apply patches, and administer eye drops. This study assessed the risks associated with such assistance by reviewing medication-related incidents across 106 residential care facilities between April 1, 2015, and March 31, 2016. An analysis of incident reports showed that all incidents were minor, with no serious outcomes. The incidents were categorized into four types: dropped drugs, misdelivery/misuse of medicines, forgetting to take medicines, and loss of medicines, with dropped drugs being the most frequent. Most incidents occurred in the morning and primarily involved residents with intermediate nursing care needs. These findings indicate a low risk of serious incidents because of medication assistance from non-medical staff. However, the frequency and nature of the incidents were influenced by the timing of medication administration and the care needs of the residents. These insights highlight the need for customized approaches to medication assistance, considering the residents' care levels and potentially optimizing medication administration times to improve safety in residential care settings.
    MeSH term(s) Humans ; Aged ; Risk Management ; Japan
    Language English
    Publishing date 2024-02-28
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 2568828-5
    ISSN 1881-784X ; 1881-784X
    ISSN (online) 1881-784X
    ISSN 1881-784X
    DOI 10.5582/ddt.2023.01073
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top